Covered recipient · General Payments record
STEPHANIE KLEIN LYNCH
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2021–2024
$2,055.93
- Reported across 87 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $733.98 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $236.06 | 15 |
| GLAUKOS CORPORATION | $97.64 | 3 |
| Sandoz Inc. | $68.97 | 2 |
| Alimera Sciences, Inc. | $64.21 | 3 |
| Alcon Laboratories Inc | $63.01 | 3 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $57.41 | 2 |
| Tarsus Pharmaceuticals, Inc. | $48.32 | 2 |
| Amgen Inc. | $32.38 | 2 |
| Dompe US, Inc. | $26.13 | 1 |
| Bausch & Lomb Americas Inc. | $24.21 | 1 |
| SANOFI PASTEUR INC. | $15.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.15 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104915705 | CMS |
| ABBVIE INC. | $15.36 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104915707 | CMS |
| ABBVIE INC. | $23.20 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104915709 | CMS |
| ABBVIE INC. | $21.83 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104915711 | CMS |
| ABBVIE INC. | $3.80 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104915713 | CMS |
| ABBVIE INC. | $2.14 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104915715 | CMS |
| ABBVIE INC. | $25.62 | 07/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104915717 | CMS |
| ABBVIE INC. | $6.38 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104915719 | CMS |
| ABBVIE INC. | $34.00 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104915721 | CMS |
| ABBVIE INC. | $2.04 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104915723 | CMS |
| ABBVIE INC. | $12.00 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104915725 | CMS |
| ABBVIE INC. | $19.02 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104915727 | CMS |
| ABBVIE INC. | $21.08 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104915729 | CMS |
| ABBVIE INC. | $24.76 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104915731 | CMS |
| ABBVIE INC. | $1.68 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104915733 | CMS |
| Alcon Vision LLC | $25.59 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110715629 | CMS |
| Alcon Vision LLC | $16.38 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110715625 | CMS |
| Alcon Vision LLC | $21.04 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110715627 | CMS |
| Alimera Sciences, Inc. | $19.85 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092840225 | CMS |
| Alimera Sciences, Inc. | $19.43 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092836884 | CMS |
| Alimera Sciences, Inc. | $24.93 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092830334 | CMS |
| Amgen Inc. | $13.17 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115887709 | CMS |
| Amgen Inc. | $19.21 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115887716 | CMS |
| Bausch & Lomb Americas Inc. | $24.21 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140451940 | CMS |
| Dompe US, Inc. | $26.13 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151416300 | CMS |
| Glaukos Corporation | $22.22 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151988470 | CMS |
| Glaukos Corporation | $47.56 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151981980 | CMS |
| Glaukos Corporation | $27.86 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151981978 | CMS |
| Sandoz Inc. | $31.15 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089368302 | CMS |
| Sandoz Inc. | $37.82 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089368332 | CMS |
| SANOFI PASTEUR INC. | $15.64 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128759570 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $30.65 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152203865 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $26.76 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152203867 | CMS |
| Tarsus Pharmaceuticals, Inc. | $23.48 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139113887 | CMS |
| Tarsus Pharmaceuticals, Inc. | $24.84 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139113889 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.